149 related articles for article (PubMed ID: 465297)
1. Total urinary and free serum hydroxyproline in metastatic bone disease.
Gasser AB; Depierre D; Courvoisier B
Br J Cancer; 1979 Mar; 39(3):280-3. PubMed ID: 465297
[TBL] [Abstract][Full Text] [Related]
2. [Hydroxyproline in the diagnosis of bone metastases in breast cancer].
Gasser AB; Depierre D; Alberto P; Courvoisier B
Schweiz Med Wochenschr; 1977 Jul; 107(28):984-6. PubMed ID: 897640
[TBL] [Abstract][Full Text] [Related]
3. Free serum hydroxyproline and total urinary hydroxyproline for the detection of skeletal metastasis.
Gasser AB; Depierre D; Mermillod B; Courvoisier B
Br J Cancer; 1982 Mar; 45(3):477-81. PubMed ID: 7041941
[No Abstract] [Full Text] [Related]
4. [Urinary and serum hydroxyproline in the diagnosis of bone metastases of prostatic cancer].
Gasser AB; Jeannet C; Depierre D; Courvoisier B
Schweiz Med Wochenschr; 1981 Feb; 111(8):246-51. PubMed ID: 7233140
[TBL] [Abstract][Full Text] [Related]
5. Urinary excretion of glycosaminoglycans and hydroxyproline in Paget's disease of bone, compared with neoplastic invasion of bone.
Bower L; Manley G
J Clin Pathol; 1981 Oct; 34(10):1097-101. PubMed ID: 7309892
[TBL] [Abstract][Full Text] [Related]
6. Relevance of hydroxyproline excretion to bone metastasis in breast cancer.
Gielen F; Dequeker J; Drochmans A; Wildiers J; Merlevede M
Br J Cancer; 1976 Sep; 34(3):279-85. PubMed ID: 974001
[TBL] [Abstract][Full Text] [Related]
7. Urinary hydroxyproline excretion as a marker of bone metastasis in prostatic cancer.
Rinsho K; Aoyagi K
Tohoku J Exp Med; 1982 Aug; 137(4):461-2. PubMed ID: 7123546
[TBL] [Abstract][Full Text] [Related]
8. The measurement of urinary amino-terminal telopeptides of type I collagen to monitor bone resorption in patients with primary hyperparathyroidism.
Minisola S; Pacitti MT; Rosso R; Pellegrino C; Ombricolo E; Pisani D; Romagnoli E; Damiani C; Aliberti G; Scarda A; Mazzuoli SF
J Endocrinol Invest; 1997 Oct; 20(9):559-65. PubMed ID: 9413811
[TBL] [Abstract][Full Text] [Related]
9. Postabsorptive urinary hydroxyproline test in patients with metastatic bone disease from breast cancer.
Niell HB; Palmieri GM; Neely CL; McDonald MW
Arch Intern Med; 1981 Oct; 141(11):1471-3. PubMed ID: 7283558
[TBL] [Abstract][Full Text] [Related]
10. [Investigation on urinary hydroxyproline--influence of skin collagen on urinary hydroxyproline and its adjustment by hydroxyproline--creatinine ratio].
Yamada Y
Nihon Seikeigeka Gakkai Zasshi; 1970 Aug; 44(8):601-12. PubMed ID: 5530072
[No Abstract] [Full Text] [Related]
11. Total urinary hydroxyproline excretion before and after hypophysectomy in patients with bone metastases from breast carcinoma.
Ditzel J; Jordal R; Riskaer N
Acta Endocrinol (Copenh); 1968 Nov; 59(3):353-61. PubMed ID: 5754976
[No Abstract] [Full Text] [Related]
12. Urinary hydroxyproline excretion in carcinoma of the breast.
Cuschieri A; Felgate RA
Br J Exp Pathol; 1972 Jun; 53(3):237-41. PubMed ID: 5055709
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyproline excretion in patients with breast cancer and response to treatment.
Powles TJ; Leese CL; Bondy PK
Br Med J; 1975 Apr; 2(5964):164-6. PubMed ID: 1125725
[TBL] [Abstract][Full Text] [Related]
14. Early morning hydroxyproline excretion in patients with breast cancer.
Powles TJ; Rosset G; Leese CL; Bondy PK
Cancer; 1976 Dec; 38(6):2564-6. PubMed ID: 1000483
[TBL] [Abstract][Full Text] [Related]
15. Relationship between bone uptake of 99mTc-pyrophosphate and hydroxyproline in blood and urine.
Wiegmann T; Kirsh J; Rosenthall L; Kaye M
J Nucl Med; 1976 Aug; 17(8):711-4. PubMed ID: 180269
[TBL] [Abstract][Full Text] [Related]
16. [Use of urinary hydroxyproline excretion as a marker of bone metastases in prostatic cancer (1)].
Kurokawa K; Imai K; Yamanaka H; Tomaru Y; Kitaura K
Hinyokika Kiyo; 1985 Dec; 31(12):2119-25. PubMed ID: 2421558
[TBL] [Abstract][Full Text] [Related]
17. Urinary hydroxyproline excretion in carcinoma of the prostate. A comparison of 4 different modes of assessment and its role as a marker.
Mundy AR
Br J Urol; 1979 Dec; 51(6):570-4. PubMed ID: 534843
[TBL] [Abstract][Full Text] [Related]
18. [Creatinine-hydroxyproline index in healthy subjects, in hyperthyroidism and in bone neoplasms].
Radom S; Sienczewska-Burzyńska J; Jaruga-Dolińska E; Zulawski M
Pol Arch Med Wewn; 1971 Sep; 47(3):257-64. PubMed ID: 5171080
[No Abstract] [Full Text] [Related]
19. Total and nondialyzable hydroxyproline excretion in Stage D2 prostate cancer.
Hopkins SC; Palmieri GM; Niell HB; Moinuddin M; Soloway MS
Cancer; 1984 Jan; 53(1):117-21. PubMed ID: 6689994
[TBL] [Abstract][Full Text] [Related]
20. Urinary excretion of glycosaminoglycans in disseminated neoplasm.
Manley G; Bower L; Anson A
J Clin Pathol; 1978 May; 31(5):447-53. PubMed ID: 649771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
